During the recent session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 1.03 million, with the beta value of the company hitting 2.02. The 52-week high
In the last trading session, 8.42 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.03. Most recently the company’s
In the last trading session, 3.46 million shares of the Petros Pharmaceuticals Inc (NASDAQ:PTPI) were traded, and its beta was 2.09. Most recently the company’s
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares stood at 10.74 million during the last session, with the company’s beta value hitting 2.02. At the close of
Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.89 and has seen 32.5 million shares traded in the last trading session. The company, currently
Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.89 and has seen 32.5 million shares traded in the last trading session. The company, currently
Petros Pharmaceuticals Inc (NASDAQ:PTPI) has a beta value of 1.89 and has seen 106.55 million shares traded in the last trading session. The company, currently
During the last session, Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares were 1.17 million, with the beta value of the company hitting 1.90. At the end
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.89. At the close of
In last trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 0.44 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
